Clinical Trial Update: An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2) [Phase 3]

View source ↗

Summary

Phase 3 Gemini 2 trial compared dolutegravir with lamivudine against dolutegravir with tenofovir/emtricitabine in treatment-naïve HIV patients; results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Dolutegravir (dolutegravir)
• Lamivudine (lamivudine)
• Tenofovir/emtricitabine (tenofovir/emtricitabine)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus, HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2019-04-22